Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP Cryopreserved Leukopaks significantly decrease lead time AllCells, the industry leader in the procurement and customization of human-derived hematological tissues and services, is pleased to announce the launch of its In Stock GMP Cryopreserved Leukopaks. While donor […]
Expansion of GMP capabilities to support the rapidly growing cell and gene therapy industry AllCells Alameda, CA Expands GMP Processing Capabilities AllCells, the industry leader in the procurement and customization of human-derived hematological tissues and services, is pleased to announce the expansion of its flagship processing facility in Alameda, California. The expansion includes the addition […]
Alameda, CA – August 31, 2021. AllCells is committed to providing the best-in-class third-party services complementary to our high-quality products. Due to the increasing demand for extended donor testing, we have added Eurofins Donor and Product Testing as an approved supplier for serology and sterility testing. The addition of Eurofins Donor and Product Testing will […]
Alameda, CA – September 15, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today the addition of Cryopreserved Leukopaks to their extensive product portfolio. Get the quality of fresh cells with the convenience of cryopreserved cells with this new product offering. Benefits include: High-Quality […]
Alameda, CA – August 13, 2020. AllCells, the leading provider of primary cells supporting biomedical research and commercialization of pharmacological and cellular therapies, announced today that it has expanded its portfolio of primary cells with the launch of the Guaranteed Cell-count Leukopaks. AllCells is committed to the success of your workflow and removing donor-to-donor variability […]
Dear Valued Customer, As part of our commitment to quality, we are continuously improving our processes, products, and logistics. To this end, we wanted to notify our Leukopak customers of a change that will contribute to the improved quality of our Whole LP family of products. In support of many of our Clinical Grade LP […]
February 7, 2019 Walkersville, MD (USA) / Basel (CH) – Lonza and AllCells have entered into a private label partnership for the manufacture and global commercialization of an extensive range of hematopoietic primary cells. This partnership expands Lonza’s broad offering of hematopoietic cell lines and enables cell biologists to easily access a wide selection of […]
May 15, 2018 ALAMEDA, Calif.–(BUSINESS WIRE)–AllCells, LLC, the leading supplier of blood-derived cells and services for immuno- and cell therapy development, announced today that it has changed its business model to respond more quickly to research needs, delivering fresh products in as little as three days. AllCells, since its founding 20 years ago by research […]
